Vaccine effectiveness against hospitalisation with COVID-19 prior to and during Delta circulation in Europe in adults aged 60+ years:I-MOVe-COVID-19 and ECDC hospital networks, January-December 2021 (CROSBI ID 728371)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Rose, Angela MC ; Mazagatos, Clara, Nonković, Diana ; et al
I-MOVE-COVID-19 and ECDC primary care study team
engleski
Vaccine effectiveness against hospitalisation with COVID-19 prior to and during Delta circulation in Europe in adults aged 60+ years:I-MOVe-COVID-19 and ECDC hospital networks, January-December 2021
For mRNA vaccines, protection against hospitalisation with COVID-19 prior to dominant circulation of the Delta variant was higher than during predominant Delta circulation, particularly for the 80+ age group.
COVID-19, ; Delta variant ; Europe ; SARS-COV-2 ; multicentre study ; vaccine efffectiveness
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
353-353.
2022.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
OPTIONS for Control of Influenza XI (conference)
poster
01.01.2022-01.01.2022
Belfast, United Kingdom
